MDP — Medexus Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapSuper Stock

Annual balance sheet for Medexus Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	18.7	10	13.1	5.25	24
Net Total Accounts Receivable
Net Total Receivables	18.8	14.4	22.4	24	13.3
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	58.6	49.1	73	72.5	80.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.795	1.22	0.899	0.778	0.689
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	149	139	161	156	172
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	39.9	48.1	83.5	66.2	97.3
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	130	121	139	125	120
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	18	17.8	22.4	30.3	52.1
Total Liabilities & Shareholders' Equity	149	139	161	156	172
Total Common Shares Outstanding